196 related articles for article (PubMed ID: 19350549)
1. High-resolution array CGH identifies novel regions of genomic alteration in intermediate-risk prostate cancer.
Ishkanian AS; Mallof CA; Ho J; Meng A; Albert M; Syed A; van der Kwast T; Milosevic M; Yoshimoto M; Squire JA; Lam WL; Bristow RG
Prostate; 2009 Jul; 69(10):1091-100. PubMed ID: 19350549
[TBL] [Abstract][Full Text] [Related]
2. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.
Ishkanian AS; Zafarana G; Thoms J; Bristow RG
Acta Oncol; 2010 Oct; 49(7):888-94. PubMed ID: 20590366
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer.
Tsukamoto Y; Uchida T; Karnan S; Noguchi T; Nguyen LT; Tanigawa M; Takeuchi I; Matsuura K; Hijiya N; Nakada C; Kishida T; Kawahara K; Ito H; Murakami K; Fujioka T; Seto M; Moriyama M
J Pathol; 2008 Dec; 216(4):471-82. PubMed ID: 18798223
[TBL] [Abstract][Full Text] [Related]
4. Minimum altered regions in early prostate cancer progression identified by high resolution whole genome tiling path BAC array comparative hybridization.
Watson SK; Woolcock BW; Fee JN; Bainbridge TC; Webber D; Kinahan TJ; Lam WL; Vielkind JR
Prostate; 2009 Jun; 69(9):961-75. PubMed ID: 19267368
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling reveals alternative genetic pathways of prostate tumorigenesis.
Lapointe J; Li C; Giacomini CP; Salari K; Huang S; Wang P; Ferrari M; Hernandez-Boussard T; Brooks JD; Pollack JR
Cancer Res; 2007 Sep; 67(18):8504-10. PubMed ID: 17875689
[TBL] [Abstract][Full Text] [Related]
6. Loss of a small region around the PTEN locus is a major chromosome 10 alteration in prostate cancer xenografts and cell lines.
Hermans KG; van Alewijk DC; Veltman JA; van Weerden W; van Kessel AG; Trapman J
Genes Chromosomes Cancer; 2004 Mar; 39(3):171-84. PubMed ID: 14732919
[TBL] [Abstract][Full Text] [Related]
7. LSAMP, a novel candidate tumor suppressor gene in human osteosarcomas, identified by array comparative genomic hybridization.
Kresse SH; Ohnstad HO; Paulsen EB; Bjerkehagen B; Szuhai K; Serra M; Schaefer KL; Myklebost O; Meza-Zepeda LA
Genes Chromosomes Cancer; 2009 Aug; 48(8):679-93. PubMed ID: 19441093
[TBL] [Abstract][Full Text] [Related]
8. High-resolution array comparative genomic hybridization of chromosome arm 8q: evaluation of genetic progression markers for prostate cancer.
van Duin M; van Marion R; Vissers K; Watson JE; van Weerden WM; Schröder FH; Hop WC; van der Kwast TH; Collins C; van Dekken H
Genes Chromosomes Cancer; 2005 Dec; 44(4):438-49. PubMed ID: 16130124
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridization onto cDNA microarrays.
Clark J; Edwards S; Feber A; Flohr P; John M; Giddings I; Crossland S; Stratton MR; Wooster R; Campbell C; Cooper CS
Oncogene; 2003 Feb; 22(8):1247-52. PubMed ID: 12606952
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of genomic aberrations associated with prostate cancer progression.
Kim JH; Dhanasekaran SM; Mehra R; Tomlins SA; Gu W; Yu J; Kumar-Sinha C; Cao X; Dash A; Wang L; Ghosh D; Shedden K; Montie JE; Rubin MA; Pienta KJ; Shah RB; Chinnaiyan AM
Cancer Res; 2007 Sep; 67(17):8229-39. PubMed ID: 17804737
[TBL] [Abstract][Full Text] [Related]
11. Simultaneously detection of genomic and expression alterations in prostate cancer using cDNA microarray.
Jiang M; Li M; Fu X; Huang Y; Qian H; Sun R; Mao Y; Xie Y; Li Y
Prostate; 2008 Oct; 68(14):1496-509. PubMed ID: 18366025
[TBL] [Abstract][Full Text] [Related]
12. Identification of candidate tumour suppressor gene loci for Hodgkin and Reed-Sternberg cells by characterisation of homozygous deletions in classical Hodgkin lymphoma cell lines.
Giefing M; Arnemann J; Martin-Subero JI; Nieländer I; Bug S; Hartmann S; Arnold N; Tiacci E; Frank M; Hansmann ML; Küppers R; Siebert R
Br J Haematol; 2008 Sep; 142(6):916-24. PubMed ID: 18671701
[TBL] [Abstract][Full Text] [Related]
13. Comparative genomic hybridization on mouse cDNA microarrays and its application to a murine lymphoma model.
Sander S; Bullinger L; Karlsson A; Giuriato S; Hernandez-Boussard T; Felsher DW; Pollack JR
Oncogene; 2005 Sep; 24(40):6101-7. PubMed ID: 16007205
[TBL] [Abstract][Full Text] [Related]
14. Array-based comparative genomic hybridization of mapped BAC DNA clones to screen for chromosome 14 copy number abnormalities in meningiomas.
Espinosa AB; Mackintosh C; Maíllo A; Gutierrez L; Sousa P; Merino M; Ortiz J; de Alava E; Orfao A; Tabernero MD
Eur J Hum Genet; 2008 Dec; 16(12):1450-8. PubMed ID: 18628790
[TBL] [Abstract][Full Text] [Related]
15. Detection of novel amplicons in prostate cancer by comprehensive genomic profiling of prostate cancer cell lines using oligonucleotide-based arrayCGH.
Kamradt J; Jung V; Wahrheit K; Tolosi L; Rahnenfuehrer J; Schilling M; Walker R; Davis S; Stoeckle M; Meltzer P; Wullich B
PLoS One; 2007 Aug; 2(8):e769. PubMed ID: 17712417
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array.
Tørring N; Borre M; Sørensen KD; Andersen CL; Wiuf C; Ørntoft TF
Br J Cancer; 2007 Feb; 96(3):499-506. PubMed ID: 17245344
[TBL] [Abstract][Full Text] [Related]
17. Detection of recurrent copy number loss at Yp11.2 involving TSPY gene cluster in prostate cancer using array-based comparative genomic hybridization.
Vijayakumar S; Hall DC; Reveles XT; Troyer DA; Thompson IM; Garcia D; Xiang R; Leach RJ; Johnson-Pais TL; Naylor SL
Cancer Res; 2006 Apr; 66(8):4055-64. PubMed ID: 16618725
[TBL] [Abstract][Full Text] [Related]
18. Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines.
Fadlelmola FM; Zhou M; de Leeuw RJ; Dosanjh NS; Harmer K; Huntsman D; Lam WL; Banerjee D
Mol Cancer; 2008 Jan; 7():2. PubMed ID: 18179710
[TBL] [Abstract][Full Text] [Related]
19. Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: identification of genetic indicators that predict patient outcome.
Loukopoulos P; Shibata T; Katoh H; Kokubu A; Sakamoto M; Yamazaki K; Kosuge T; Kanai Y; Hosoda F; Imoto I; Ohki M; Inazawa J; Hirohashi S
Cancer Sci; 2007 Mar; 98(3):392-400. PubMed ID: 17233815
[TBL] [Abstract][Full Text] [Related]
20. Genomic profiles associated with early micrometastasis in lung cancer: relevance of 4q deletion.
Wrage M; Ruosaari S; Eijk PP; Kaifi JT; Hollmén J; Yekebas EF; Izbicki JR; Brakenhoff RH; Streichert T; Riethdorf S; Glatzel M; Ylstra B; Pantel K; Wikman H
Clin Cancer Res; 2009 Mar; 15(5):1566-74. PubMed ID: 19208797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]